Chinese vaccine producer Kanghua Biological has raised 1.056 billion yuan ($149 million) in an initial public offering (IPO) on Shenzhen’s startup board ChiNext on Tuesday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
